Identification and in vitro characterization of a new series of potent and highly selective G9a inhibitors as novel anti-fibroadipogenic agents.

Randazzo P, Sinisi R, Gornati D, Bertuolo S, Bencheva L, De Matteo M, Nibbio M, Monteagudo E, Turcano L, Bianconi V, Peruzzi G, Summa V, Bresciani A, Mozzetta C, Di Fabio R

Open source

DOI
10.1016/j.bmcl.2022.128858
Published
2022 Sep 15
Container
Bioorganic & medicinal chemistry letters
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.bmcl.2022.128858,
  title = {Identification and in vitro characterization of a new series of potent and highly selective G9a inhibitors as novel anti-fibroadipogenic agents.},
  author = {Randazzo P and Sinisi R and Gornati D and Bertuolo S and Bencheva L and De Matteo M and Nibbio M and Monteagudo E and Turcano L and Bianconi V and Peruzzi G and Summa V and Bresciani A and Mozzetta C and Di Fabio R},
  year = {2022},
  journal = {Bioorganic \& medicinal chemistry letters},
  doi = {10.1016/j.bmcl.2022.128858},
  url = {https://doi.org/10.1016/j.bmcl.2022.128858}
}

RIS

TY  - JOUR
TI  - Identification and in vitro characterization of a new series of potent and highly selective G9a inhibitors as novel anti-fibroadipogenic agents.
AU  - Randazzo P
AU  - Sinisi R
AU  - Gornati D
AU  - Bertuolo S
AU  - Bencheva L
AU  - De Matteo M
AU  - Nibbio M
AU  - Monteagudo E
AU  - Turcano L
AU  - Bianconi V
AU  - Peruzzi G
AU  - Summa V
AU  - Bresciani A
AU  - Mozzetta C
AU  - Di Fabio R
PY  - 2022
JO  - Bioorganic & medicinal chemistry letters
DO  - 10.1016/j.bmcl.2022.128858
UR  - https://doi.org/10.1016/j.bmcl.2022.128858
ER  - 

APA

P, R., R, S., D, G., S, B., L, B., M, D. M., M, N., E, M., L, T., V, B., G, P., V, S., A, B., C, M., & R, D. F. (2022). Identification and in vitro characterization of a new series of potent and highly selective G9a inhibitors as novel anti-fibroadipogenic agents.. Bioorganic & medicinal chemistry letters. https://doi.org/10.1016/j.bmcl.2022.128858

Source records